基本信息
浏览量:1
职业迁徙
个人简介
Research interests
Health Economic Evaluation
Economics of pharmaceuticals
Pharmacoepidemiology
Health Technology Assessment
Research area keywords
Health EconomicsEconomic EvaluationPharmacoepidemiologyHealth Services ResearchPharmaceuticalsHealth Technology AssessmentsDecision Analytic ModellingMedication Safety and EffectivenessComparative Effectiveness ResearchPropensity Score Modelling
Her qualifications include BPharm(Hons), MPH, PhD. She has extensive expertise in health economic evaluation, pharmacoepidemiology, health technology assessment and in the linkage and analysis of population-based healthcare data from Australian and international healthcare settings (United Kingdom and Hong Kong).
She evaluates the clinical- and cost-effectiveness of pharmaceutical submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) and conducts independent research into the comparative effectiveness, safety and value for money of pharmaceuticals in real-world populations. In her work, Laura undertakes epidemiological and economic modelling, and economic evaluations alongside clinical trials. Her research spans several chronic diseases, including atrial fibrillation, dementia and haematological malignancies. She has recently received competitively awarded research funding from the Medical Research Future Fund and The Australian Digital Health Agency.
研究兴趣
论文共 16 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn